Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Orinova


Technopole Temis Innovation
18 Rue Alain Savary
F-25000 Besançon
Téléphone : +33 (0)6 81 76 36 52
Email : jm.zeil@orinova.fr

Jean-Marc ZEIL: CEO
Gautier LAURENT: CSO

#Health & Well-being # Biotherapies

  • Oncology
  • Dual therapy
  • Glioblastoma
  • Gold Nanoparticle

Field of activity


ORINOVA is developing a breakthrough innovation in oncology with a patented nanomedicine incorporating a unique dual therapy: a chemotherapy molecule combined with gold nanoparticles. This combination amplifies the effect of radiotherapy and optimizes tumor targeting, thus limiting side effects for patients. This intelligent nano-object could revolutionize the treatment of particularly resistant solid tumors, such as glioblastoma.

BACKGROUND
ORINOVA was founded in October 2024, building on more than 10 years of R&D in
Besançon. ORINOVA specializes in the development of nanospheres for oncology.

DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY 

ORINOVA nanospheres contain gold nanoparticles and chemotherapy molecules, enabling dual therapy for the treatment of localized solid tumors such as glioblastoma or recurrent prostate cancer.

ACHIEVEMENTS / COLLABORATIONS / HIGHLIGHTS

A first in vivo POC demonstrated excellent results on glioblastoma. We collaborate with the University of BFC, via its 2 chrono environment and Right research laboratories.

COLLABORATIONS SOUGHT 

  • Search for partners in oncology, radiation oncology, university hospitals.
  • Fundraising to finance our R&D
  • .

    • FURTHER INFORMATION

      1 patent
      1 employee

      STRENGHTS

      Worldwide patent, POC in vivo excellent.
      Patent team disruptive innovation
      INNOVATION ASSETS

      Dual therapy via nanosphere.

    Share
    Companies Directory

    #Health and Well-being


    In the same field

    AGS Therapeutics - log

    AGS Therapeutics

    AGS Therapeutics is a biotech company pioneering the use of microalgae extracellular vesicles (MEVs) as a universal delivery system for innovative therapeutics, vaccines and gene therapies.

    Discover
    Logo biotech 5H45

    5 H 45

    A protein-based nanofilm technology offers the first non-toxic, semi-permanent hair treatment that allows users to safely change their hair style without damage.

    Discover
    BioHive - Genopole Company Shaker - Gene.iO

    BioHive

    BioHive provides advanced analysis for dermatological products using innovative skin organoids derived from human stem cells, for toxicity and efficacy evaluations.

    Discover
    Alt Biotech - Genopole's Company Gene.iO#3

    Alt Biotech

    Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

    Discover
    Vitropep -entreprise genopole

    Vitropep

    Vitropep developed a unique technology allowing to inject certain peptides without cold chain and with self-administration.

    Discover
    Exosome Analytics - Entreprise génopolitaine

    Exosome Analytics

    Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

    Discover

    bYoRNA

    Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis

    Discover
    Kyron.Bio - Genopole's Company

    Kyron.Bio

    Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

    Discover
    CGenetix - Entreprise génopolitaine

    CGenetix

    CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

    Discover
    EndoGene.Bio - Genopole's Company

    EndoGene.Bio

    Research & development for an in vitro diagnostic tool for endometriosis

    Discover
    Exosome Analytics - Entreprise génopolitaine

    Exosome Analytics

    Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

    Discover
    Maison M - Startup génopolitaine

    Maison M

    Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

    Discover
    Cell Environment - Genopole's company

    Cell Environment

    Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

    Discover
    Innovhem - Entreprise génopolitaine

    Innovhem

    Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

    Discover
    StemSelect - Entreprise génopolitaine

    StemSelect

    The aim of StemSelect is to pave the way for a general access to cell therapy. The company develops a rapid isolation method of stem cells derived from one’s own fat tissue.

    Discover
    Synsight - Genopole's Company

    Synsight

    Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

    Discover
    Sebia - Genopole's Company

    Sebia

    Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

    Discover
    IntegraGen - Genopole's Company

    Integragen

    IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

    Discover
    Généthon - Genopole's Laboratory

    Généthon

    Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

    Discover

    Enterome

    Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

    Discover
    View all >
    With the support from
    Région île de France